Table 1

Binding of protein S to domain-specific monoclonal antibodies and enhancement of APC-mediated cleavage of FVa at Arg306 by protein S

WT PSChimera IChimera IIChimera III
MK 21 (Gla) 1.93 ± 0.78 1.67 ± 0.33 1.62 ± 0.78 1.92 ± 0.83 
MK 41 (EGF3-EGF4) 0.76 ± 0.18 1.00 ± 0.32 0.50 ± 0.26 0.75 ± 0.46 
MK 54 (EGF1) 0.25 ± 0.13 0.21 ± 0.12 0.17 ± 0.06 0.20 ± 0.07 
MK 67 (TSR) 0.22 ± 0.09 0.18 ± 0.03 0.13 ± 0.06 0.15 ± 0.09 
EC50 for FVaR506Q/R679Q inactivation 5.18 ± 0.36 5.20 ± 1.19 6.31 ± 0.53 4.92 ± 0.95 
WT PSChimera IChimera IIChimera III
MK 21 (Gla) 1.93 ± 0.78 1.67 ± 0.33 1.62 ± 0.78 1.92 ± 0.83 
MK 41 (EGF3-EGF4) 0.76 ± 0.18 1.00 ± 0.32 0.50 ± 0.26 0.75 ± 0.46 
MK 54 (EGF1) 0.25 ± 0.13 0.21 ± 0.12 0.17 ± 0.06 0.20 ± 0.07 
MK 67 (TSR) 0.22 ± 0.09 0.18 ± 0.03 0.13 ± 0.06 0.15 ± 0.09 
EC50 for FVaR506Q/R679Q inactivation 5.18 ± 0.36 5.20 ± 1.19 6.31 ± 0.53 4.92 ± 0.95 

PS, protein S.

Kd app/EC50 values obtained from 3 independent experiments are given in nanomolars and are expressed as mean ± SD.

Close Modal

or Create an Account

Close Modal
Close Modal